Cannabis Growth Cannabis has been a booming industry in the USA and many other countries in the past decade. This followed a slow, but steady trend toward full legalization, even if doing so at the US ...

Children exposed to maternal cannabis use disorder during pregnancy and postpartum have an increased risk for later behavioral disorders.

Canopy Growth (CGC) stock receives a Neutral rating from Zuanic & Associates, citing financial challenges and market uncertainties.

At Monday night’s Woodstock Selectboard meeting, vice chair Susan Ford asked the board to consider reversing its decision to allow retail cannabis in town.

Children exposed to their mother's cannabis use during pregnancy and after birth are three times more likely to develop ...

Purple Day, the international epilepsy awareness day, is today and it encourages people to wear purple and engage in ...

Australian researchers have developed a clever way to supercharge the effects of cannabidiol (CBD), a compound used to treat ...

Innovative Industrial Properties, Gibraltar Industries, and Tilray are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares in companies ...

Penington Institute has written to several Australian premiers and chief ministers, urging them to fix road laws for medical ...

Cronos shows strong fundamentals and growth potential. Learn why CRON stock is a strong buy despite regulatory headwinds.

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and ...

Scientists have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.